Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR

被引:38
作者
Coupry, I
Monnet, L
Attia, AAM
Taine, L
Lacombe, D
Arveiler, B
机构
[1] Univ Victor Segalen Bordeaux 2, Lab Genet Humaine Dev & Canc, F-33076 Bordeaux, France
[2] CHU Bordeaux, Serv Genet Med, Bordeaux, France
关键词
Rubinstein-Taybi syndrome; RTS; CBP; CREBBP; quantitative real-time PCR; RT-QPCR;
D O I
10.1002/humu.20001
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Rubinstein-Taybi syndrome (RTS) is a well,defined syndrome characterized by facial abnormalities, broad thumbs, broad big toes, and growth and mental retardation as the main clinical features. RTS was shown to be associated with disruption of the CREB-binding protein gene CBP (CREBBP), either by gross chromosomal rearrangements or by point mutations. Translocations and inversions involving chromosome band 16p13.3 form the minority of CBP mutations, whereas microdeletions occur more frequently (about 10%). Most deletion studies in RTS are performed by FISH analysis, and five cosmids must be used to cover the whole of the CBP gene, which spreads over 150 kb. Here we report the design of gene dosage assays by real-time quantitative PCR that are targeted on three exons located respectively at the 5' end (exon 2), in the middle (exon 12), and at the 3' end (exon 30) of the CBP gene. This technique proved to be efficient and powerful in finding deletions and complementary to the other available techniques, since it allowed us to identify deletions at the 3' end of the gene that had been missed by FISH analysis, and to refine some deletion breakpoints. Our results therefore suggest that real-time quantitative PCR is a useful technique to be included in the deletion search in RTS patients. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:278 / 284
页数:7
相关论文
共 28 条
  • [11] HENNEKAM RCM, 1993, AM J HUM GENET, V52, P255
  • [12] RUBINSTEIN-TAYBI SYNDROME WITH DENOVO RECIPROCAL TRANSLOCATION T(2-16)(P13.3-P13.3)
    IMAIZUMI, K
    KUROKI, Y
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1991, 38 (04): : 636 - 639
  • [13] CONFIRMATION OF ASSIGNMENT OF A LOCUS FOR RUBINSTEIN-TAYBI SYNDROME GENE TO 16P13.3
    LACOMBE, O
    SAURA, R
    TAINE, L
    BATTIN, J
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 44 (01): : 126 - 128
  • [14] SUBMICROSCOPIC DELETION OF CHROMOSOME REGION 16P13.3 IN A JAPANESE PATIENT WITH RUBINSTEIN-TAYBI SYNDROME
    MASUNO, M
    IMAIZUMI, K
    KUROSAWA, K
    MAKITA, Y
    PETRIJ, F
    DAUWERSE, HG
    BREUNING, MH
    KUROKI, Y
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 53 (04): : 352 - 354
  • [15] Rubinstein-Taybi syndrome with deletions of FISH probe RT1 at 16p13.3: Two UK patients
    McGaughran, JM
    Gaunt, L
    Dore, J
    Petrij, F
    Dauwerse, HG
    Donnai, D
    [J]. JOURNAL OF MEDICAL GENETICS, 1996, 33 (01) : 82 - 83
  • [16] Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations
    Petrij, F
    Dauwerse, HG
    Blough, RI
    Giles, RH
    van der Smagt, JJ
    Wallerstein, R
    Maaswinkel-Mooy, PD
    van Karnebeek, CD
    van Ommen, GJB
    van Haeringen, A
    Rubinstein, JH
    Saal, HM
    Hennekam, RCM
    Peters, DJM
    Breuning, MH
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 (03) : 168 - 176
  • [17] Petrij F, 2000, AM J MED GENET, V92, P47, DOI 10.1002/(SICI)1096-8628(20000501)92:1<47::AID-AJMG8>3.0.CO
  • [18] 2-H
  • [19] RUBINSTEIN-TAYBI SYNDROME CAUSED BY MUTATIONS IN THE TRANSCRIPTIONAL COACTIVATOR CBP
    PETRIJ, F
    GILES, RH
    DAUWERSE, HG
    SARIS, JJ
    HENNEKAM, RCM
    MASUNO, M
    TOMMERUP, N
    VANOMMEN, GJB
    GOODMAN, RH
    PETERS, DJM
    BREUNING, MH
    [J]. NATURE, 1995, 376 (6538) : 348 - 351
  • [20] PETRIJ F, 2001, METABOLIC MOL BASIS, P6167